Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/34D stock hub

FRA/34D has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/34Dis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/34D

In the news

Latest news · FRA/34D

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.6

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE8.6

P25 n/aP50 n/aP75 n/a

ROIC8.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/34D market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

EUR

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	DE
Employees	3,242
Employees Change	1%
Employees Change Percent	0.03
Enterprise value	EUR 4.1B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 3.3B
Price	EUR 63.74
Price currency	EUR
Rev Per Employee	360,596.85x
Sic	2835
Symbol	fra/34D
Website	https://int.diasorin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.23%
EV Earnings	28.67x
EV/EBIT	15.64x
EV/EBITDA	11.08x
EV/FCF	15.15x
EV/Sales	3.47x
FCF yield	8%
Forward P/E	15.57x
P/B ratio	2.24x
P/E ratio	23.65x
P/S ratio	2.87x
PE Ratio10 Y	29.82x
PE Ratio3 Y	27.08x
PE Ratio5 Y	26.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.21%
EBITDA Margin	30.3%
FCF margin	22.93%
Gross margin	64.97%
Gross Profit	EUR 759.5M
Gross Profit Growth	-4.37%
Gross Profit Growth Q	-8.33%
Gross Profit Growth3 Y	-3.97%
Gross Profit Growth5 Y	2.62%
Net Income	EUR 141.6M
Net Income Growth	-27.04%
Net Income Growth Q	-26.92%
Net Income Growth3 Y	-10.91%
Net Income Growth5 Y	-13.26%
Pretax Margin	16.65%
Profit Margin	12.11%
Profit Per Employee	EUR 43,684
ROA	6.39
Roa5y	6.91
ROE	8.55
Roe5y	14.77
ROIC	8.32
Roic5y	11.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.55%
Cagr15y	6.06%
Cagr1y	-34%
Cagr3y	-12.81%
Cagr5y	-13.4%
Div CAGR10	7.18%
Div CAGR3	5.73%
Div CAGR5	5.39%
FCF Growth	-11.44%
FCF Growth Q	-18.31%
FCF Growth3 Y	3.33%
FCF Growth5 Y	-2.75%
OCF Growth	-7.05%
OCF Growth Q	-18.31%
OCF Growth10 Y	9.1%
OCF Growth3 Y	3.65%
OCF Growth5 Y	-1.22%
Revenue Growth	-3.34x
Revenue Growth Q	-8.31x
Revenue Growth3 Y	-3.31x
Revenue Growth5 Y	3.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.46
Assets	EUR 2.5B
Current Assets	EUR 343M
Debt	EUR 711M
Debt EBITDA	EUR 1.94
Debt Equity	EUR 0.47
Debt FCF	EUR 2.65
Equity	EUR 1.5B
Interest Coverage	10.63
Liabilities	EUR 972M
Long Term Assets	EUR 2.1B
Net Cash	EUR -711M
Net Cash By Market Cap	EUR -21.23
Net Debt EBITDA	EUR 2.01
Net Debt Equity	EUR 0.47
Net Debt FCF	EUR 2.65
Tangible Book Value	EUR -321M
Tangible Book Value Per Share	EUR -6.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Working Capital	EUR 343M
Working Capital Turnover	EUR 3.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	8.33%
Dividend Growth Years	6%
Dividend per share	EUR 1.3
Dividend Years	19
Dividend Yield	2.08%
Ex Div Date	2026-05-18
Last Dividend	EUR 1.3
Payout Frequency	Annual
Payout Ratio	44.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	41.75%
1Y total return	-33.98%
200-day SMA	71.5
3Y total return	-33.73%
50-day SMA	62.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-51.29%
All Time High	211
All Time High Change	-69.79%
All Time High Date	2020-05-25
All Time Low	10.82
All Time Low Change	489.09%
All Time Low Date	2008-01-22
ATR	1.23
Ch YTD	-7.03
High	63.74
High52	96.8
High52 Date	2025-05-09
High52ch	-34.15%
Low	63.74
Low52	55.26
Low52 Date	2026-03-24
Low52ch	15.35%
Ma50ch	1.25%
Price vs 200-day SMA	-10.85%
RSI	57.3
RSI Monthly	37.82
RSI Weekly	42.03
Sharpe ratio	-1.32x
Sortino ratio	-1.46
Total Return	2.08%
Tr YTD	-7.03
Tr15y	141.74%
Tr1m	3.54%
Tr1w	9.75%
Tr3m	-14.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 259.7M
Operating Income Growth	-6.16
Operating Income Growth Q	-20.27
Operating Income Growth3 Y	-7.22
Operating Income Growth5 Y	-7.51
Operating margin	22.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,193,920%
Net Borrowing	-191,359,000
Shares Insiders	4.42%
Shares Institutions	13.26%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 256.9M
Average Volume	20.95x
Bv Per Share	28.24
CAPEX	EUR -61.7M
Ch10y	24.84
Ch15y	90.33
Ch1m	3.54
Ch1w	9.75
Ch1y	-34.83
Ch3m	-14.26
Ch3y	-36.02
Ch5y	-53.71
Ch6m	5.6
Change	0.35%
Change From Open	0
Close	63.52
Days Gap	0.35
Depreciation Amortization	94,545,500
Earnings Date	2026-05-07
EBIT	EUR 259.7M
EBITDA	EUR 354.2M
EPS	EUR 2.67
F Score	5
FCF	EUR 268M
FCF EV Yield	6.6x
Financing CF	-332,176,000
Fiscal Year End	December
Founded	1,968
Graham Number	41.56083
Graham Upside	-34.8
Income Tax	EUR 58.6M
Investing CF	-136,517,000
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 13.47
Lynch Upside	-78.86
Ma150	67.46
Ma150ch	-5.51%
Ma20	61.11
Ma20ch	4.3%
Net CF	-164,471,000
Next Earnings Date	2026-07-31
Open	63.74
P FCF Ratio	12.5
P OCF Ratio	10.16
Payment Date	2026-05-20
Ppne	265,000,000
Price Date	2026-05-08
Price EBITDA	EUR 9.46
Relative Volume	9.55x
Revenue	1,169,055,000x
SBC By Revenue	0.95x
Share Based Comp	11,111,000
Tax By Revenue	5.01x
Tax Rate	30.1%
Tr6m	5.6%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/34D dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.1%

$1.30 annual per share

Payout ratio

+44.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.4%

6 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-05-18

Performance

FRA/34D stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/34D?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.3%

Share of float held by funds and institutions

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

FRA/34D momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.3

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/34D

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/34D stock rating?

fra/34D is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/34D analysis?

The full report lives at /stocks/fra/34D/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/34D?

The latest report frames fra/34D around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/34D page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.